Baird lowered the firm’s price target on Dentsply Sirona (XRAY) to $24 from $31. The firm said with implant and equipment pressures continuing, shares were likely going to be down today. Even with the shares at all-time low valuation, Baird sees too many company-specific challenges beyond just macro to recommend stepping in at current levels.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XRAY:
- Dentsply Sirona Reports Mixed Q3 2024 Results
- Dentsply Sirona downgraded to Market Perform at Leerink on lack of visibility
- Dentsply Sirona downgraded to Market Perform from Outperform at Leerink
- DENTSPLY SIRONA Revises Outlook Amid Goodwill Impairments
- Dentsply Sirona reports Q3 adjusted EPS 50c, consensus 47c